Loading clinical trials...
Loading clinical trials...
Randomized Placebo-Controlled First-in-Human Study With GNbAC1
Conditions
Interventions
GNbAC1
GNbAC1 placebo
Start Date
July 1, 2011
Primary Completion Date
March 1, 2012
Completion Date
August 1, 2012
Last Updated
October 20, 2020
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
GeNeuro Innovation SAS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions